Safety study of an experimental drug in healthy adults
Part of Immune system & allergy clinical trials.
This trial tests a new drug, GenSci136, in healthy adults to see if it's safe and how the body processes it. If you qualify, you would receive the drug and be monitored for side effects.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be between 18 and 45 years old.
- Your weight must be at least 110 pounds if male or 99 pounds if female, with a BMI between 18 and 28.
- You must agree to use highly effective birth control from screening through the end of the study if you are of childbearing age.
- You must not have any allergies to the study drug or its ingredients.
- You must have no tattoos, sunburn, or scars at the injection area on your body.
- You must not have used recreational drugs (like marijuana, cocaine, or ketamine) recently or have a history of drug abuse.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new drug called GenSci120, given as multiple injections under the skin, to see if it is safe in healthy adults. It will also measure how the drug moves through the body and how it affects certain immune markers.
This trial tests a new medicine called GenSci161 to see if it is safe and how the body handles it. It is for healthy volunteers aged 18 to 45 who are willing to follow study rules and use birth control.
This is an early-stage safety test of a new injectable drug (SSS68) in healthy volunteers with no serious medical conditions. Researchers will give one dose under the skin and monitor how your body tolerates it over time.
This study tests a new injection called GenSci164 in healthy adults. It helps find out how the drug works in the body and if it is safe. Participants receive the injection and are monitored for effects.
This is an early-stage safety study testing a new injectable medication (GenSci155) that affects growth and metabolism. Researchers want to make sure it's safe and well-tolerated in healthy volunteers before testing it in patients with medical conditions.
This study tests a new medicine (INCA033989) given as a shot or IV in healthy adults to see how the body processes it and if it's safe.
Hear when a new Autoimmune Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.